26 January 2021: Clinical Research
Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy
Feng Yu BCEF , Ruiguo Zhang CDF , Guizhi Zhang B , Zhaowei Meng B , Xiaohua Liu B , Yajing He B , Jian Tan D , Renfei Wang ADG*DOI: 10.12659/MSM.928796
Med Sci Monit 2021; 27:e928796
Table 2 Univariate analyses for the continuous variables.
| Characteristics | Efficacy | t | P | |
|---|---|---|---|---|
| Cured group | Uncured group | |||
| Age (years) | 43.6±14.3 | 42.0±14.3 | 0.766 | 0.445 |
| RAIU (%) | 60.0±10.9 | 56.7±9.6 | 2.188 | * |
| RAIUmax (%) | 70.4±11.3 | 71.0±11.7 | −0.357 | 0.722 |
| Teff (d) | 4.3±0.6 | 3.3±0.7 | 10.163 | * |
| TW (g) | 32.3±20.8 | 32.5±23.5 | −0.061 | 0.952 |
| TID (mCi) | 8.8±4.3 | 7.1±3.8 | 2.753 | * |
| TD (Gy) | 74.2±7.9 | 59.7±10.3 | 10.190 | * |
| IDPG (mCi) | 12.5±8.6 | 9.4±3.6 | 3.636 | * |
| TID – total iodine dose; IDPG – iodine dose per gram of thyroid tissue. * Statistically significant values | ||||